Novo Integrated Sciences Wholly Owned Canadian Subsidiary, Acenzia, Selected To Participate In Protein Industries Canada Program To Develop Plant Based Protein Products; Project Investment Amounts Expected To Total $5.4M With Acenzia Investing $600K, Protein Industries Canada Investing $2.3M, And Two Other Partner Companies Investing $2.5M

Project investment amounts expected to total $5.4 million with Acenzia investing $600 thousand, Protein Industries Canada investing $2.3 million, and two other partner companies investing $2.5 million

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") announced today that its wholly owned Canadian subsidiary, Acenzia Inc. ("Acenzia"), has been selected by Protein Industries Canada to participate in a new project to bring new protein products with a superior nutritional amino acid profile to the global marketplace. The total project is expected to see approximately $5.4 million invested into the development, reformulation, and commercialization of three consumer-ready protein products: a modular, a ready-to-mix and a ready-to-drink low-volume liquid protein. Acenzia will invest approximately $600,000, Protein Industries Canada will invest approximately $2.3 million, and two other partner companies together will invest approximately $2.5 million over three defined phases.

The project partners are utilizing innovative solutions to offer alternative plant-based protein options that meet the quality, sensory and muscle health benefits of whey protein isolate.